SM
Sahajanand Medical Technologies IPO Date, Price Band & GMP
Upcoming
Mainboard IPO
BSE, NSE
Opens in 2 days
· updated 7 hours ago
Price band
₹327 – 344
GMP
+₹42
Est. listing price₹386
Est. listing gain12.21%
Issue size₹475.48 Cr
Sahajanand Medical Technologies IPO Details
Open DateThu, 15 Oct 2026
Close DateMon, 19 Oct 2026
Listing DateFri, 23 Oct 2026
Listing AtBSE, NSE
Price Band₹327 – 344 per share
Lot Size43 shares
Min. Investment₹14,792
Issue Size₹475.48 Cr
Sahajanand Medical Technologies IPO Dates & Timeline
Tentative dates follow SEBI's T+3 listing timelineIPO Opens
Thu, 15 Oct
IPO Closes
Mon, 19 Oct
Basis of Allotment
Tue, 20 Oct
Tentative
Refunds Initiated
Wed, 21 Oct
Tentative
Shares Credited to Demat
Wed, 21 Oct
Tentative
Listing Date
Fri, 23 Oct
Add dates to your calendar:
Apple / Outlook (.ics)
Google: Opens
Google: Closes
Google: Allotment
Google: Listing
Sahajanand Medical Technologies IPO GMP Today
All IPO GMP
GMP today
+₹42
Est. listing price
₹386
Est. gain %
12.21%
Est. profit / lot
₹1,806
GMP is an unofficial grey-market indicator and can change quickly. It does not guarantee listing gains.
Try the GMP calculator · What is GMP? · GMP of all IPOs
Will you apply for Sahajanand Medical Technologies IPO?
Visitor opinion poll, not investment advice.
Sahajanand Medical Technologies IPO GMP Trend
12 Oct – 13 Oct · +₹7| Date | GMP | Est. listing |
|---|---|---|
| Tue, 13 Oct | +₹42 | ₹386 |
| Mon, 12 Oct | +₹35 | ₹379 |
Sahajanand Medical Technologies IPO Allotment Status
The registrar for this IPO is MUFG Intime (Link Intime). You can also check on the exchange websites using your PAN or application number.
New to this? Read how to check IPO allotment status or see all IPOs awaiting allotment.
Sahajanand Medical Technologies IPO Lot Size & Minimum Investment
At upper price band of ₹344| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹1,92,296 |
| S-HNI (Min) | 14 | 602 | ₹2,07,088 |
| S-HNI (Max) | 67 | 2,881 | ₹9,91,064 |
| B-HNI (Min) | 68 | 2,924 | ₹10,05,856 |
Sahajanand Medical Technologies IPO analysis: what the numbers say
Sahajanand Medical Technologies is a medical technology company engaged in the development, manufacturing and marketing of technologically advanced medical devices, primarily focused on vascular intervention and structural heart intervention. The ₹475.48 Cr issue is entirely an offer for sale, so the money goes to the selling shareholders, not the company. Promoter holding falls from 40.82% to 36.2% after the issue.
The grey market premium (GMP) is ₹42, 12.2% above the upper price, which points to a listing around ₹386; GMP is unofficial and changes quickly.
Worked out by IPO Darbaar from the offer document, exchange data and the latest GMP. For information only, not a recommendation.
Sahajanand Medical Technologies IPO Issue Structure
Fresh issue — (0%)
Offer for sale ₹475 Cr (100%)
Face value₹1 / share
Market cap (post issue)—
Promoter holding (pre)40.82%
Promoter holding (post)36.2%
- Promoters
- Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen, Shree Hari Trust
- Book running lead managers
- Motilal Oswal Investment Advisors Ltd.
Sahajanand Medical Technologies IPO Strengths & Risks
Strengths
- Extensive global sales and marketing network.
- Strong research and development capabilities.
- Diversified and integrated manufacturing facilities.
- Leadership in India and key international markets.
Risks
- The company faces strict regulations in many countries, including the EU Medical Device Regulation and India's Drugs and Cosmetics Act. Any unfavorable regulatory action to preserve certifications could negatively impact the company's capacity to market products.
- Risks to the company's three manufacturing facilities include underutilized capacity, outdated machinery, operational disruptions, and quality control issues.
- The corporation depends on a small number of suppliers, with the top 10 contributing 63.61%, 59.15%, 64.37%, and 58.88% of total purchases in the three months ending June 30, 2026, and in Fiscal 2026, 2025, and 2024, respectively.
Sahajanand Medical Technologies Key Performance Indicators (KPIs)
ROE10.35%
ROCE11.57%
RoNW10.6%
Debt / Equity0.27
About Sahajanand Medical Technologies IPO
Sahajanand Medical Technologies is a mainboard IPO worth ₹475.48 crore with a price band of ₹327 – 344 per share. The issue opens on 15 October 2026 and closes on 19 October 2026. Shares are expected to list on 23 October 2026 on BSE, NSE.
Sahajanand Medical Technologies IPO is a Mainboard IPO with an issue size of Rs. 475.48 Cr Shares by Sahajanand Medical Technologies Limited, which is a medical technology company engaged in the development, manufacturing and marketing of technologically advanced medical devices, primarily focused on vascular intervention and structural heart intervention.
Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons (DCBs). The Company focuses on research and development, precision manufacturing and clinically supported product innovation. Its flagship brands include Supraflex Cruz, Cocoon and Hydra, serving different areas of interventional cardiology.
The Company operates three manufacturing facilities, two in India and one in Thailand, supported by two R&D centres in India and Thailand. As of June 30, 2026, it had 119 patents granted globally, 78 patent applications in the pipeline and five design registrations in India. Its products were marketed in 77 countries in Fiscal 2026, through direct, hybrid and distributor-led models, with established market presence in India, Europe and other international markets.
This new IPO is to be launched on 15 October 2026, and its ‘initial public offering’ will end on 19 October 2026.
Sahajanand Medical Technologies IPO: FAQs
What is Sahajanand Medical Technologies IPO GMP today?
As of 13 Oct 2026, the Sahajanand Medical Technologies IPO GMP is ₹42, or 12.2% over the upper price band, which points to a listing price of around ₹386. GMP is an unofficial grey-market indicator and can change quickly.
What is the price band of Sahajanand Medical Technologies IPO?
The Sahajanand Medical Technologies IPO price band is ₹327 – 344 per share and the issue size is ₹475.48 crore.
What is the lot size and minimum investment for Sahajanand Medical Technologies IPO?
One lot of Sahajanand Medical Technologies IPO has 43 shares. The minimum application for retail investors is 1 lot (43 shares), which costs ₹14,792 at the upper price band.
When does Sahajanand Medical Technologies IPO open and close?
Sahajanand Medical Technologies IPO opens for subscription on Thursday, 15 October 2026 and closes on Monday, 19 October 2026. Bids are accepted until 5 PM on the closing day.
What is the Sahajanand Medical Technologies IPO allotment date?
The basis of allotment for Sahajanand Medical Technologies IPO is expected on Tuesday, 20 October 2026, one working day after the issue closes (SEBI T+3 timeline).
How to check Sahajanand Medical Technologies IPO allotment status?
Visit the website of the registrar, MUFG Intime (Link Intime), select Sahajanand Medical Technologies IPO and search by PAN or application number. You can also check on the IPO allotment status page or on the BSE and NSE websites.
When is Sahajanand Medical Technologies IPO listing date?
Sahajanand Medical Technologies shares are expected to list on BSE, NSE on Friday, 23 October 2026.
Is Sahajanand Medical Technologies a mainboard or SME IPO?
Sahajanand Medical Technologies is a mainboard IPO, listing on the main board of BSE, NSE.
Last updated 13 Oct 2026, 6:18 AM IST. GMP is unofficial and indicative; dates after the issue closes are tentative. Not investment advice.